Placeholder Banner

BIO Files Amicus Brief on Case Addressing the America Invents Act’s Joinder Provision

December 28, 2018

BIO filed an amicus brief in Proppant Express Investments, LLC, Proppant Express Solutions, LLC, v. Oren Technologies, LLC in front of the Patent Trial and Appeal Board.

BIO members devote billions of dollars annually to researching and developing biotechnological healthcare, agricultural, environmental, and industrial products to cure diseases, improve food security, create alternative energy sources, and deliver many other benefits. However, these products typically require lengthy, costly, and resource-intensive research and development.

In light of these investments, BIO’s members depend upon a stable, predictable, and transparent patent system encouraging patent-holders to maintain and enforce strong patents. In particular, BIO’s members have a significant interest in ensuring the America Invents Act’s joinder provision, 35 U.S.C. § 315(c), is interpreted as Congress intended, and that only proper parties can join an existing inter partes review (IPR) proceeding.

Related Resources
IPR2018-00914 - Amicus Brief By BIO
Proppant Express Investments vs. Oren Technologies (BIO Brief as Amicus Curiae)
Discover More
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 
Natural Alternatives International v. Creative Compounds (BIO Brief as Amicus Curiae supporting appellant in the US Court of Appeals for the Federal Circuit)